Bryant Barr
Founding Partner at Penny Jar Capital
San Francisco, United States
Bryant Barr, Founding Partner at Penny Jar Capital is an active investor based in San Francisco, United States. This profile covers what Bryant Barr backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCMicro VC
- Stages
- Pre SeedSeed
- Invests in
- FintechConsumer & Retail
- Location
- San Francisco, United States
- Typical check
- $150K
How to reach Bryant Barr
Angels and operators like Bryant Barr reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Bryant Barr
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Bryant Barr invest in?
Bryant Barr invests in Fintech and Consumer & Retail, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does Bryant Barr invest at?
Bryant Barr typically invests at Pre Seed and Seed. Lead with traction that fits the stage when you reach out.
What is Bryant Barr's typical check size?
Bryant Barr typically writes checks around $150K. Use it as a signal for whether your raise fits their stage.
How do I contact Bryant Barr?
Unlock Bryant Barr's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.